Literatur
-
1
Akira S.
Mammalian Toll-like receptors.
Curr Opin Immunol.
2003;
15
5-11
-
2
Atanackovic D, Nierhaus A, Neumeier M, Hossfeld D K, Hegewisch-Becker S.
41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.
Cancer Immunol Immunother.
2002;
51
603-613
-
3
Asea A, Kraeft S K, Kurt-Jones E A. et al .
HSP70 stimulates cytokine production through a CD14 dependent pathway, demonstrating a dual role as a chaperone and cytokine.
Nat Med.
2000;
6
435-442
-
4
Asea A, Rehli M, Kabingu E. et al .
Novel signal transduction pathway utilized by extracellular HSP70: role of TLR2 and TLR4.
J Biol Chem.
2002;
277
15028-15034
-
5
Banchereau J, Steinmann R M.
Dendritic cells and the control of immunity.
Nature.
1999;
392
245-252
-
6
Basu S, Binder R J, Ramalingam T, Srivastava P K.
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.
Immunity.
2001;
14
303-313
-
7
Bausinger H, Lipsker D, Ziylan U. et al .
Endotoxin-free heat-shock protein 70 fails to induce APC activation.
Eur J Immunol.
2002;
32
3708-3713
-
8
Becker T, Hartl F U, Wieland F.
CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes.
J Cell Biol.
2002;
158
1277-1285
-
9
Belli F, Testori A, Rivoltini L. et al .
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.
J Clin Oncol.
2002;
20
4169-4180
-
10
Bethke K, Staib F, Distler M. et al .
Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: superiority of HSP60.
J Immunol.
2002;
169
6141-6148
-
11
Binder R J, Blachere N E, Srivastava P K.
Heat shock protein-chaperoned peptides but not free peptides introduced into the cytosol are presented efficiently by major histocompatibility complex I molecules.
J Biol Chem.
2001;
276
17 163-17 171
-
12
Breloer M, More S, Dorner B, Fleischer B, von Bonin A.
Hitzeschockproteine als Gefahrensignale: HSP60 verstärkt die antigenspezifische Aktivierung primärer T-Zellen.
Immunologie Aktuell.
2001;
2
64-66
-
13
Buchner J, Walter S.
Molecular chaperones-Cellular machines for protein folding.
Angew Chem Int Ed.
2002;
41
1098-1113
-
14
Bukau B, Horwich A L.
The HSP70 and HSP60 chaperone machines.
Cell.
1998;
92
351-366
-
15
Castelli C, Ciupitu A M, Rini F. et al .
Human heat shock 70 peptide complexes specifically activate antimelanoma T cells.
Cancer Res.
2001;
61
222-227
-
16
Chen W, Syldath U, Bellmann K, Burkart V, Kolb H.
Human 60 kDa heat shock protein. A danger signal to the innate immune response.
J Immunol.
1999;
162
3212-3219
-
17
Ciupitu A M, Petersson M, Odonnell C L. et al .
Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes.
J Exp Med.
1998;
187
685-691
-
18
Delneste Y, Magistrelli G, Gauchat J F. et al .
Involvement of LOX-1 in Dendritic Cell-Mediated Antigen Cross-Presentation.
Immunitiy.
2002;
17
352-362
-
19
Falk M, Issels R D.
Hyperthermia in oncology.
Int J Hyperthermia.
2001;
17
1-18
-
20
Flohe S B, Bruggemann J, Lendemans S. et al .
Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype.
J Immunol.
2003;
170
2340-2348
-
21
Fuller J, Issels R, Slosman D, Guillet J G, Soussi T, Polla B S.
Cancer and the heat shock response.
Eur J Cancer.
1994;
12
1884-1891
-
22
Gehrmann M, Pfister K, Hutzler P, Gastpar R, Margulis B, Multhoff G.
Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels.
Biol Chem.
2002;
383
1715-1725
-
23
Janetzki S, Palla D, Rosenhauer V, Lochs H, Lewis J J, Srivastava P K.
Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparation: a pilot study.
Int J Cancer.
2000;
88
232-238
-
24
Janeway C A Jr., Medzhitov R.
Innate immune recognition.
Annu Rev Immunol.
2002;
20
197-216
-
25
Keilholz U, Weber J, Finke J H. et al .
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.
J Immunother.
2002;
25
97-138
-
26
Kuppner M, Gastpar R, Gelwer S. et al .
The role of heat shock protein (HSP70) in dendritic cell maturation: HSP70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocytes precursors.
Eur J Immunol.
2001;
31
1602-1609
-
27
Matzinger P.
Tolerance, danger, and the extended family.
Annu Rev Immunol.
1994;
12
991-945
-
28
Medzhitov R, Preston-Hurlburt P, Janeway C A.
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.
Nature.
1997;
388
394-397
-
29
Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile R G.
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock proteins expression.
Nat Med.
1998;
4
581-587
-
30
Milani V, Noessner E, Ghose S. et al .
Heat shock protein 70: role in antigen presentation and immune stimulation.
Int J Hyperthermia.
2002;
18
563-575
-
31
Milarski K L, Morimoto R I.
Expression of human HSP70 during the synthetic phase of the cell cycle.
Proc Natl Acad Sci USA.
1986;
83
9517-9521 SE>
-
32
Multhoff G.
Activation of natural killer cells by heat shock protein 70.
Int J Hyperthermia.
2002;
18
576-585
-
33
Multhoff G, Botzler C, Jennen L, Schmidt J, Ellwart J, Issels R.
Heat shock protein 72 on tumour cells: a recognition structure for natural killer cells.
J Immunol.
1997;
158
4341-4350
-
34
Noessner E, Gastpar R, Milani V. et al .
Tumor-derived heat shock protein 70 peptide complexes are cross-presented by human dendritic cells.
J Immunol.
2002;
169
5424-5432
-
35
Parmiani G, Castelli C, Dalerba P. et al .
Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?.
J Natl Cancer Inst.
2002;
94
805-818
-
36
Singh-Jasuja H, Hilf N, Arnold-Schild D, Schild H.
The role of heat shock proteins and their receptors in the activation of the immune system.
Biol Chem.
2001;
382
629-636
-
37
Singh-Jasuja H, Toes R E, Spee P. et al .
Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
J Exp Med.
2000;
191
1965-1974
-
38
Singh-Jasuja H, Scherer H U, Hilf N, Arnold-Schild D, Rammensee H G, Toes R EM, Schild A.
The heat shock protein gp96 induces maturation of dendritic cells and down regulation of its receptor.
Eur J Immunol.
2000;
30
2211-2215
-
39
Somersan S, Larsson M, Fonteneau J, Basu S, Srivastava P, Bhardway N.
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.
J Immunol.
2001;
167
4844-4852
-
40
Srivastava P K.
Immunotherapy of human cancer: lessons from mice.
Nature Immunology.
2000;
1
363-366
-
41
Srivastava P K, DeLeo A B, Old L J.
Tumor rejection antigens of chemically induced sarcomas in inbred mice.
Proc Natl Acad Sci USA.
1986;
83
3407-3411
-
42
Srivastava P, Menoret A, Basu S, Binder R, McQuade K.
Heat shock protein come of age: primitive functions acquire new roles in an adaptive world.
Immunity.
1998;
8
657-665
-
43
Srivastava P K, Udono H.
Heat shock protein-peptide complexes in cancer immunotherapy.
Curr Opin Immunol.
1994;
6
728-732
-
44
Stewart J R, Gibbs F A.
Hyperthermia in the treatment of cancer. Perspectives on its promise and its problems.
Cancer.
1984;
54
2823-2830
-
45
Udono H, Srivastava P K.
Heat shock protein 70-associated peptides elicit specific cancer immunity.
J Exp Med.
1993;
178
1391-96
-
46
Udono H, Srivastava P K.
Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, HSP90 and HSP70.
J Immunol.
1994;
152
5398-5403
-
47
Vabulas R M, Ahmad-Nejad P, da Costa C. et al .
Endocytosed HSP60 s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells.
J Biol Chem.
2001;
276
31 332-31 339
-
48
Vabulas R M, Ahmad-Nejad P, Ghose S, Kirschning C J, Issels R D, Wagner H.
HSP70 as endogenous stimulus of Toll/interleukin-1 receptor signal pathway.
J Biol Chem.
2002;
277
15 107-15 112
-
49
Vabulas R M, Braedel S, Hilf N. et al .
The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway.
J Biol Chem.
2002;
277
20 847-20 853
-
50
Vabulas R M, Wagner H, Schild H.
Heat shock proteins as Ligands for Toll-like receptors.
Curr Top Microbiol Immunol.
2002;
270
169-184
-
51
Wang X Y, Kazim L, Repasky E, Subjeck J.
Characterization of heat shock protein 110 and glucose-regulated 170 as cancer vaccine and the effect of fever-range hyperthermia on vaccine activity.
J Immunol.
2001;
165
490-497
-
52
Wells A D, Malkovsky M.
Heat shock proteins, tumour immunogenicity and antigen presentation: an integrated view.
Immunol Today.
2000;
21
129-132
1 Dieses Forschungsprojekt wird durch das SFB455-Projekt B9 und das Krebshilfe-Projekt 7023011-Is/2 gefördert.
Valeria Milani
KKG Hyperthermie, Medizinische Klinik III, Klinikum Großhadern
Marchioninistraße 15
81377 München
Phone: 089/7099403
Fax: 089/7099450
Email: milani@gsf.de
